Antimicrobial Resistance

49 Results

number of items to display at a time

Feb 23, 2022

Spotlight 2021–2022

Spotlight 2021-2022 highlights selected RAND Europe projects that address the important issues of our time. It also features research that is poised to make a difference in the coming year.
Research

Feb 1, 2022

Progress Report: AMR Industry Alliance 2021 Survey

An analysis of AMR Industry Alliance contributions to the fight against antimicrobial resistance.
Research

Dec 3, 2021

A Rapid Evidence Assessment Exploring Whether Antimicrobial Resistance Complicates Non-Infectious Health Conditions and Healthcare Services, 2010–20

This study explored what impact AMR is currently having on non-communicable health conditions, or areas of health services, via a rapid evidence assessment of 101 studies.
Project

Sep 30, 2021

The impact of antimicrobial resistance on modern medicine

The Wellcome Trust commissioned RAND Europe to explore of the impacts of antimicrobial resistance for non-infectious health conditions and on health services. We conducted a Rapid Evidence Assessment of the literature on this topic.
Research

Sep 28, 2021

How Is Modern Medicine Being Affected by Drug-Resistant Infections?

This report explores the relationship between drug-resistant bacterial infections, focusing on antibiotic-resistant infections and conditions such as HIV, cancer and diabetes and medical treatment including surgery, organ transplant and ICU care.
Project

Feb 12, 2021

Understanding industry contributions to the fight against antimicrobial resistance

The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. In an ongoing project, RAND Europe has been commissioned by the AMR Industry Alliance to assess the progress of its members in contributing to tackling AMR.
Research

Nov 21, 2019

When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada

Researchers examined the current impacts of AMR on Canada's healthcare system, the future impact on Canada's GDP, and how widespread resistance could influence the day-to-day lives of Canadians.
Project

Aug 13, 2018

RAND Europe Focus on Antimicrobial Resistance (AMR)

RAND Europe's research has provided evidence to support policy and decision making to address antimicrobial resistance (AMR).
Project

Apr 16, 2018

AMR historical foresight

Researchers are examining complex and enduring policy issues that have implications for public health (climate change and tobacco control) to gain a new perspective on how to tackle AMR. The team will look at how historical analysis can be used in future approaches to scenario planning and policymaking, with a particular focus on AMR policy.
Research

Mar 28, 2017

Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes

To examine factors associated with isolation precaution use in nursing home (NH) residents with multidrug-resistant organism (MDRO) infection.
Research

Mar 28, 2017

Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits

Patterns of antibiotic prescribing behavior show that both telemedicine and office-based clinicians over-prescribed antibiotics to treat acute respiratory infections, but telemedicine clinicians tended to prescribe broad-spectrum antibiotics.
Dec 31, 2016

Spotlight on 2016

Spotlight, RAND Europe's annual review, features ways that our objective research and analysis expanded perspectives in 2016 to provide policy and decision makers the evidence and facts during a year of highly charged political debates.

Antimicrobial Resistance

Antimicrobial Resistance

The Economic Costs of Antimicrobial Resistance

Europe's Fight Against Antimicrobial Resistance

Explore RAND’s Work on this Topic

Error

Spotlight 2021–2022

Progress Report: AMR Industry Alliance 2021 Survey

A Rapid Evidence Assessment Exploring Whether Antimicrobial Resistance Complicates Non-Infectious Health Conditions and Healthcare Services, 2010–20

The impact of antimicrobial resistance on modern medicine

How Is Modern Medicine Being Affected by Drug-Resistant Infections?

Understanding industry contributions to the fight against antimicrobial resistance

When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada

RAND Europe Focus on Antimicrobial Resistance (AMR)

AMR historical foresight

Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes

Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits

Spotlight on 2016

Oops! An unexpected error has occurred.

RAND Headquarters

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Antimicrobial Resistance

Antimicrobial Resistance

The Economic Costs of Antimicrobial Resistance

Europe's Fight Against Antimicrobial Resistance

Explore RAND’s Work on this Topic

Error

Spotlight 2021–2022

Progress Report: AMR Industry Alliance 2021 Survey

A Rapid Evidence Assessment Exploring Whether Antimicrobial Resistance Complicates Non-Infectious Health Conditions and Healthcare Services, 2010–20

The impact of antimicrobial resistance on modern medicine

How Is Modern Medicine Being Affected by Drug-Resistant Infections?

Understanding industry contributions to the fight against antimicrobial resistance

When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada

RAND Europe Focus on Antimicrobial Resistance (AMR)

AMR historical foresight

Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes

Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits

Spotlight on 2016

Oops! An unexpected error has occurred.